Interdisciplinary cooperation between LMU and Helmholtz Munich supported by Bavarian Research Foundation
Unlike other forms of blood cancer, acute myeloid leukemia (AML) cannot currently be treated with CAR-T cell immunotherapy. The reason is that…
Mehr erfahren